Foamy virus vectors for suicide gene therapy

被引:0
|
作者
U Nestler
M Heinkelein
M Lücke
J Meixensberger
W Scheurlen
A Kretschmer
A Rethwilm
机构
[1] Institut für Virologie und Immunbiologie,
[2] Universität Würzburg,undefined
[3] Neurochirurgische Universitätsklinik,undefined
[4] Universitätskinderklinik,undefined
[5] Universität Würzburg,undefined
[6] Bayer AG,undefined
[7] Pharma-Research,undefined
[8] Kinderklinik des Universitätsklinikums der Stadt Mannheim,undefined
来源
Gene Therapy | 1997年 / 4卷
关键词
foamy virus vectors; suicide gene therapy; thymidine kinase; cytosine deaminase; polynucleoside phosphatase;
D O I
暂无
中图分类号
学科分类号
摘要
To improve the delivery of so-called suicide genes into tumors, recombinant retroviruses were constructed by inserting the herpes virus type 1 (HSV-1) thymidine kinase (tk), the E. coli cytosine deaminase (cd) and polynucleoside phosphorylase (pnp), or the jellyfish gene for the green fluorescent protein (gfp) into a foamy virus (FV)-derived replication-competent vector (pFOV-7). Expression and stability of the inserted foreign gene was analyzed by immunoblot and polymerase chain reaction (PCR). The functionality of the suicide genes was determined by a metabolic assay on virus vector infected cells and treatment with the respective prodrugs. In terms of vector stability and effectiveness of specific cell killing a virus transducing the pnp gene (FOV-7/pnp) was superior to those using the other two suicide genes. FOV-7/pnp is a candidate virus for suicide gene delivery into solid tumors.
引用
收藏
页码:1270 / 1277
页数:7
相关论文
共 50 条
  • [41] Transient foamy virus vector production by adenovirus vectors
    RA Russell
    G Vassaux
    P Martin-Duque
    MO McClure
    Gene Therapy, 2004, 11 : 310 - 316
  • [42] Improved foamy virus vectors with minimal viral sequences
    Trobridge, G
    Josephson, N
    Vassilopoulos, G
    Mac, J
    Russell, DW
    MOLECULAR THERAPY, 2002, 6 (03) : 321 - 328
  • [43] Optimizing Foamy Virus Vectors That Inhibit HIV Infection
    Taylor, Jason A.
    Vojtech, Lucia
    Olson, Erik M.
    Allen, James M.
    Trobridge, Grant D.
    Russell, David W.
    Richard, Robert E.
    MOLECULAR THERAPY, 2006, 13 : S141 - S142
  • [44] Transient foamy virus vector production by adenovirus vectors
    Russell, RA
    Vassaux, G
    Martin-Duque, P
    McClure, MO
    GENE THERAPY, 2004, 11 (03) : 310 - 316
  • [45] Cell-cycle dependence of foamy virus vectors
    Patton, GS
    Erlwein, O
    McClure, MO
    JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 2925 - 2930
  • [46] Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs
    Park, J
    Nadeau, P
    Zucali, JR
    Johnson, CM
    Mergia, A
    VIROLOGY, 2005, 343 (02) : 275 - 282
  • [47] Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors
    Vassilopoulos, G
    Trobridge, G
    Josephson, NC
    Russell, DW
    BLOOD, 2001, 98 (03) : 604 - 609
  • [48] Comparison of Immortalization Potential of Gamma-Retroviral, Lentiviral and Foamy Virus Gene Transfer Vectors
    Ikawa, Yasuhiro
    Uchiyama, Toru
    Jagadeesh, Guridevi Jayashree
    Candotti, Fabio
    BLOOD, 2011, 118 (21) : 1347 - 1347
  • [49] Development of Gene Transfer System for Wiskott-Aldrich Syndrome Using Foamy Virus Vectors
    Uchiyama, Toru
    Shimizu, Masaki
    Thrasher, Adrian J.
    Candotti, Fabio
    MOLECULAR THERAPY, 2009, 17 : S375 - S376
  • [50] Gene therapy models of X-linked severe combined immunodeficiency and Wiskott-Aldrich Syndrome using foamy virus vectors
    Uchiyama, T.
    Horino, S.
    So, T.
    Jagadeesh, G. J.
    Ishii, N.
    Candotti, F.
    HUMAN GENE THERAPY, 2013, 24 (12) : A150 - A150